This session spotlights the transformative potential of specialty diagnostics in the race to detect disease earlier and act faster. From at-home collection to novel biomarkers and liquid biopsies, cutting-edge tools are redefining proactive care. Drawing on examples in cancer, neurodegenerative disease, and advanced genetic testing, the discussion reveals how diagnostics are shaping the future of prevention and early detection. Join us as we explore how strategic investments and cross-sector collaborations are accelerating innovation toward a more convenient, accessible, data-driven model of care.
